# Meishangjie Biotechnology

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/meishangjie-biotechnology

- Industry: Biotechnology
- Headquarters: Suzhou, China
- Latest round: Series A (Oct 10, 2025)
- Investors on record: 5

## About

Established in 2021 and based in Suzhou, China, Meishangjie Biotechnology is a genetic recombinant fibrillated collagen product development company.

In July 2024, Meishangjie Biotechnology closed a series A funding. In October 2025, Meishangjie Biotechnology raised an undisclosed amount of series A+ funding from new investors Sumin Investment and Originvest Capital.

The company’s main business is in the innovation of biotechnological solutions, focusing on the synthesis of bio-active collagens. The company’s self-developed products include a range of anti-aging skincare products and Class II medical devices. Its products are used in the field of dermatology, ophthalmology, and surgical applications. Meishangjie Biotechnology generates revenue by offering synthetic biology skin care products and medical devices.

The series A+ funding will be used by the company to accelerate the company's research and development in the field of genetically engineered synthetic biology, promote the clinical transformation and market expansion of recombinant humanized collagen products, and continue to optimize the technology platform. The company plans to establish a new Class III medical device production line in Yixing, China.

## Funding rounds

- Series A, Oct 10, 2025 — Sumin Investment, Originvest Capital
- Series A, Jul 9, 2024 — Royal Sunward Equity Fund Management, Zhangjiagang Industrial Capital Center, Jinxin Capital

## Investors

- Royal Sunward Equity Fund Management (https://capitalatlas.ai/funds/royal-sunward-equity-fund-management) — Series A
- Zhangjiagang Industrial Capital Center (https://capitalatlas.ai/funds/zhangjiagang-industrial-capital-center) — Series A
- Jinxin Capital — Series A
- Sumin Investment (https://capitalatlas.ai/funds/sumin-investment) — Series A
- Originvest Capital (https://capitalatlas.ai/funds/originvest-capital) — Series A